Cargando…

Ninety-Day Oral Toxicity Assessment of an Alternative Biopolymer for Controlled Release Drug Delivery Systems Obtained from Cassava Starch Acetate

The large consumption of biodegradable films from cassava starch acetate (FCSA) as ingredients in food and pharmaceutical products requires the assessment of the possible toxicity of these products. The aim of this study was to investigate the toxicity of biodegradable film from cassava starch aceta...

Descripción completa

Detalles Bibliográficos
Autores principales: Jesus, Douglas Rossi, Barbosa, Lorena Neris, Prando, Thiago Bruno Lima, Martins, Leonardo Franco, Gasparotto, Francielli, Guedes, Karla Moraes Rocha, Dragunski, Douglas Cardoso, Lourenço, Emerson Luiz Botelho, Dalsenter, Paulo Roberto, Gasparotto Junior, Arquimedes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4584237/
https://www.ncbi.nlm.nih.gov/pubmed/26451154
http://dx.doi.org/10.1155/2015/390416
_version_ 1782391955706085376
author Jesus, Douglas Rossi
Barbosa, Lorena Neris
Prando, Thiago Bruno Lima
Martins, Leonardo Franco
Gasparotto, Francielli
Guedes, Karla Moraes Rocha
Dragunski, Douglas Cardoso
Lourenço, Emerson Luiz Botelho
Dalsenter, Paulo Roberto
Gasparotto Junior, Arquimedes
author_facet Jesus, Douglas Rossi
Barbosa, Lorena Neris
Prando, Thiago Bruno Lima
Martins, Leonardo Franco
Gasparotto, Francielli
Guedes, Karla Moraes Rocha
Dragunski, Douglas Cardoso
Lourenço, Emerson Luiz Botelho
Dalsenter, Paulo Roberto
Gasparotto Junior, Arquimedes
author_sort Jesus, Douglas Rossi
collection PubMed
description The large consumption of biodegradable films from cassava starch acetate (FCSA) as ingredients in food and pharmaceutical products requires the assessment of the possible toxicity of these products. The aim of this study was to investigate the toxicity of biodegradable film from cassava starch acetate after oral exposure of Wistar rats for 90 days. The amount of food consumed and the body weight were weekly monitored. Blood and urine samples were obtained for the assessment of serum parameters and renal function. Histopathological analyses in target organs were also performed. No evidence of clinical toxicity in hematological, biochemical, or renal parameters in the FCSA-treated animals was found. In addition, relative organ weight and histopathological evaluations did not differ between groups treated with FCSA and control. Data obtained suggest that the subchronic exposure to FCSA does not cause obvious signs of toxicity in Wistar rats, indicating possible safety of this biofilm.
format Online
Article
Text
id pubmed-4584237
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-45842372015-10-08 Ninety-Day Oral Toxicity Assessment of an Alternative Biopolymer for Controlled Release Drug Delivery Systems Obtained from Cassava Starch Acetate Jesus, Douglas Rossi Barbosa, Lorena Neris Prando, Thiago Bruno Lima Martins, Leonardo Franco Gasparotto, Francielli Guedes, Karla Moraes Rocha Dragunski, Douglas Cardoso Lourenço, Emerson Luiz Botelho Dalsenter, Paulo Roberto Gasparotto Junior, Arquimedes Evid Based Complement Alternat Med Research Article The large consumption of biodegradable films from cassava starch acetate (FCSA) as ingredients in food and pharmaceutical products requires the assessment of the possible toxicity of these products. The aim of this study was to investigate the toxicity of biodegradable film from cassava starch acetate after oral exposure of Wistar rats for 90 days. The amount of food consumed and the body weight were weekly monitored. Blood and urine samples were obtained for the assessment of serum parameters and renal function. Histopathological analyses in target organs were also performed. No evidence of clinical toxicity in hematological, biochemical, or renal parameters in the FCSA-treated animals was found. In addition, relative organ weight and histopathological evaluations did not differ between groups treated with FCSA and control. Data obtained suggest that the subchronic exposure to FCSA does not cause obvious signs of toxicity in Wistar rats, indicating possible safety of this biofilm. Hindawi Publishing Corporation 2015 2015-09-14 /pmc/articles/PMC4584237/ /pubmed/26451154 http://dx.doi.org/10.1155/2015/390416 Text en Copyright © 2015 Douglas Rossi Jesus et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Jesus, Douglas Rossi
Barbosa, Lorena Neris
Prando, Thiago Bruno Lima
Martins, Leonardo Franco
Gasparotto, Francielli
Guedes, Karla Moraes Rocha
Dragunski, Douglas Cardoso
Lourenço, Emerson Luiz Botelho
Dalsenter, Paulo Roberto
Gasparotto Junior, Arquimedes
Ninety-Day Oral Toxicity Assessment of an Alternative Biopolymer for Controlled Release Drug Delivery Systems Obtained from Cassava Starch Acetate
title Ninety-Day Oral Toxicity Assessment of an Alternative Biopolymer for Controlled Release Drug Delivery Systems Obtained from Cassava Starch Acetate
title_full Ninety-Day Oral Toxicity Assessment of an Alternative Biopolymer for Controlled Release Drug Delivery Systems Obtained from Cassava Starch Acetate
title_fullStr Ninety-Day Oral Toxicity Assessment of an Alternative Biopolymer for Controlled Release Drug Delivery Systems Obtained from Cassava Starch Acetate
title_full_unstemmed Ninety-Day Oral Toxicity Assessment of an Alternative Biopolymer for Controlled Release Drug Delivery Systems Obtained from Cassava Starch Acetate
title_short Ninety-Day Oral Toxicity Assessment of an Alternative Biopolymer for Controlled Release Drug Delivery Systems Obtained from Cassava Starch Acetate
title_sort ninety-day oral toxicity assessment of an alternative biopolymer for controlled release drug delivery systems obtained from cassava starch acetate
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4584237/
https://www.ncbi.nlm.nih.gov/pubmed/26451154
http://dx.doi.org/10.1155/2015/390416
work_keys_str_mv AT jesusdouglasrossi ninetydayoraltoxicityassessmentofanalternativebiopolymerforcontrolledreleasedrugdeliverysystemsobtainedfromcassavastarchacetate
AT barbosalorenaneris ninetydayoraltoxicityassessmentofanalternativebiopolymerforcontrolledreleasedrugdeliverysystemsobtainedfromcassavastarchacetate
AT prandothiagobrunolima ninetydayoraltoxicityassessmentofanalternativebiopolymerforcontrolledreleasedrugdeliverysystemsobtainedfromcassavastarchacetate
AT martinsleonardofranco ninetydayoraltoxicityassessmentofanalternativebiopolymerforcontrolledreleasedrugdeliverysystemsobtainedfromcassavastarchacetate
AT gasparottofrancielli ninetydayoraltoxicityassessmentofanalternativebiopolymerforcontrolledreleasedrugdeliverysystemsobtainedfromcassavastarchacetate
AT guedeskarlamoraesrocha ninetydayoraltoxicityassessmentofanalternativebiopolymerforcontrolledreleasedrugdeliverysystemsobtainedfromcassavastarchacetate
AT dragunskidouglascardoso ninetydayoraltoxicityassessmentofanalternativebiopolymerforcontrolledreleasedrugdeliverysystemsobtainedfromcassavastarchacetate
AT lourencoemersonluizbotelho ninetydayoraltoxicityassessmentofanalternativebiopolymerforcontrolledreleasedrugdeliverysystemsobtainedfromcassavastarchacetate
AT dalsenterpauloroberto ninetydayoraltoxicityassessmentofanalternativebiopolymerforcontrolledreleasedrugdeliverysystemsobtainedfromcassavastarchacetate
AT gasparottojuniorarquimedes ninetydayoraltoxicityassessmentofanalternativebiopolymerforcontrolledreleasedrugdeliverysystemsobtainedfromcassavastarchacetate